» Articles » PMID: 33641229

Long Non-coding RNA SNHG1 Stimulates Ovarian Cancer Progression by Modulating Expression of MiR-454 and ZEB1

Overview
Journal Mol Oncol
Date 2021 Feb 28
PMID 33641229
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Ovarian cancer (OC) is highly prevalent and is associated with high mortality rates due to metastasis and relapse. In this study, we assessed the role of long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) in OC to gain further insight into mechanisms that contribute to its aggressiveness. We analyzed the correlation between SNHG1, miR-454 and zinc finger E-box-binding homeobox 1 (ZEB1) using a dual-luciferase reporter assay. Alterations in cell metastasis and invasiveness were observed using wound-healing and Transwell invasion assays, respectively. Tumor xenografts allowed us to monitor liver metastasis of mice injected with A2780 cells. We found that SNHG1 is overexpressed in OC. Downregulation of SNHG1 promoted miR-454 expression and reduced ZEB1 levels. In addition, knockdown of SNHG1, also reduced the aggressiveness of A2780 and SK-OV3 cells. Furthermore, SNHG1 downregulation by siRNA hindered cell migration and invasion; however, this effect was reversed by co-transfection of miR-454 into A2780 and SK-OV3 cells. Moreover, SNHG1 increased ZEB1 expression by downregulating miR-454 and activated Akt signaling, thereby promoting epithelial-mesenchymal transition and enhancing the invasiveness of OC cells. Tumor xenograft analyses confirmed that SNHG1 affects OC proliferation and metastasis in vivo. In summary, our data demonstrate that SNHG1 plays crucial roles in tumor progression and may be a useful maker for OC prognosis.

Citing Articles

ZEB1 promotes the immune escape of ovarian cancer through the MCSF-CCL18 axis.

Jin Y, Li G, Xu Q, Wang X Cancer Cell Int. 2025; 25(1):95.

PMID: 40089803 DOI: 10.1186/s12935-025-03724-y.


Competing endogenous RNA networks in ovarian cancer: from bench to bedside.

Derogar R, Nejadi Orang F, Shadbad M EXCLI J. 2025; 24:86-112.

PMID: 39967908 PMC: 11830916. DOI: 10.17179/excli2024-7827.


Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications.

Basu S, Nadhan R, Dhanasekaran D Cancers (Basel). 2025; 17(3).

PMID: 39941838 PMC: 11815776. DOI: 10.3390/cancers17030472.


Long non‑coding RNA SNHG1 promotes autophagy in vascular smooth muscle cells induced by facilitating CLEC7A.

Deng H, Teng W, Zhou S, Ye Z, Dong Z, Hu R Mol Med Rep. 2024; 31(1).

PMID: 39513586 PMC: 11564905. DOI: 10.3892/mmr.2024.13385.


Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms.

Zhan T, Zou Y, Han Z, Tian X, Chen M, Liu J Clin Transl Med. 2024; 14(8):e1799.

PMID: 39118300 PMC: 11310283. DOI: 10.1002/ctm2.1799.


References
1.
Vergara D, Merlot B, Lucot J, Collinet P, Vinatier D, Fournier I . Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett. 2009; 291(1):59-66. DOI: 10.1016/j.canlet.2009.09.017. View

2.
Bao X, Ren T, Huang Y, Sun K, Wang S, Liu K . Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth. Cell Death Dis. 2017; 8(2):e2605. PMC: 5386479. DOI: 10.1038/cddis.2017.31. View

3.
Mitra R, Chen X, Greenawalt E, Maulik U, Jiang W, Zhao Z . Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat Commun. 2017; 8(1):1604. PMC: 5693921. DOI: 10.1038/s41467-017-01781-0. View

4.
Duran G, Wang Y, Moisan F, Francisco E, Sikic B . Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition. Br J Cancer. 2017; 116(10):1318-1328. PMC: 5482726. DOI: 10.1038/bjc.2017.102. View

5.
Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G . The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601. DOI: 10.1038/ncb1722. View